Wall Street falls as Trump says China violated tariff terms

Wall Street indexes faced pressure Friday after Donald Trump accused China of violating a tariff agreement, escalating trade war tensions despite overall positive monthly gains for the Nasdaq and S&P 500; Trump's statement, posted on Truth Social, undermined hopes for a lasting trade resolution between the U.S. and China, overshadowing positive PCE data indicating marginal consumer spending increases. Ulta Beauty saw an 11.5% jump after raising its annual profit forecast, while Regeneron shares dropped nearly 20% following disappointing trial results for its experimental lung drug.

Analysis

U.S. equity markets experienced downward pressure on the final trading day of the month, primarily attributed to renewed U.S.-China trade tensions after former President Donald Trump accused China of breaching a tariff agreement via a Truth Social post. This development overshadowed marginally positive U.S. consumer spending data for April, which showed a year-on-year PCE price index increase of 2.1%, slightly down from March's 2.3%, yet traders maintained expectations for a Federal Reserve interest rate cut in September. Despite the day's losses, where at 11:27 a.m. ET the S&P 500 was down 0.15% to 5,903.23 and the Nasdaq Composite fell 0.36% to 19,107.53 while the Dow Jones Industrial Average was marginally up 0.01% at 42,220.39, both the Nasdaq and S&P 500 were poised for their largest monthly gains since November 2023. The Dow was also set for its first monthly gain since January. Market breadth was negative, with declining issues outnumbering advancers on both the NYSE (1.36-to-1) and Nasdaq (1.47-to-1), and seven of the 11 major S&P 500 sub-sectors declining, led by energy and information technology. Stock-specific news significantly impacted individual equities: Ulta Beauty (ULTA) shares surged 11.5% after raising its annual profit forecast and reporting strong quarterly results, whereas Regeneron (REGN) shares plummeted nearly 20% due to a failed late-stage trial for an experimental lung drug. Nvidia (NVDA) declined 2.5%, retreating from a recent rally. The market also digested recent legal developments concerning tariffs, with a federal appeals court temporarily reinstating most levies after an earlier Court of International Trade ruling had blocked them.

Key Decisions for Investors

• Investors should closely monitor pronouncements related to U.S.-China trade policy, as these continue to be a significant source of intraday market volatility and can quickly shift sentiment, impacting broad market indices and specific sectors.
• While acknowledging the strong monthly gains in major indices like the S&P 500 and Nasdaq, it is prudent to consider the potential for increased caution and a more defensive posture given the re-emergence of trade uncertainties and mixed market breadth.
• Portfolio allocations should continue to emphasize company-specific fundamentals, as evidenced by the divergent performances of Ulta Beauty (ULTA) and Regeneron (REGN), which highlight opportunities and risks independent of macroeconomic headlines.
• Observe trends in megacap growth stocks, such as Nvidia (NVDA), and the technology sector for signs of profit-taking or rotation, especially as they were leading decliners during the session despite strong recent performance.